Literature DB >> 3328244

Intratubular germ cell neoplasia.

B Gondos1, J A Migliozzi.   

Abstract

Intratubular germ cell neoplasia is now well established as a precursor to invasive germ cell tumors of the testis. The lesion is usually associated with subsequent development of typical invasive tumors if orchiectomy is not performed. Pathologic findings in intratubular neoplasia consist of germ cell abnormalities within the seminiferous tubules. The atypical cells have large round nuclei, prominent nucleoli, and abundant clear cytoplasm. They have ultrastructural and immunohistochemical characteristics of spermatogenic precursor cells present in the fetal and postnatal testis. Intratubular collections of abnormal germ cells have been found adjacent to invasive germ cell tumors in a high proportion of cases. Intratubular neoplasia occurring in the absence of testicular enlargement has been found in the following situations: cryptorchidism, in testes of some infertile men, dysgenetic testes, and in the contralateral testis following orchiectomy for germ cell cancer. Recognition of intratubular germ cell neoplasia is of special importance because detection of the most common forms of testicular cancer can be accomplished at a preinvasive stage and, therefore, prior to the opportunity for metastasis.

Entities:  

Mesh:

Year:  1987        PMID: 3328244

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

Review 1.  Microinvasive germ cell tumor of the testis.

Authors:  Finn Edler von Eyben; Grete Krag Jacobsen; Rolf Inge Skotheim
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

2.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

3.  Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia.

Authors:  H S Klys; D Whillis; G Howard; D J Harrison
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.